FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/09/2022
Voltar para busca
Dado oficial do USPTO
DEXPLORER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
05/09/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 42
Data de depósito
27/11/2020
Data de registro
22/03/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/03/2022
Última transação
22/03/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
KR
Examinador
NOVAKOVIC, MIROSLAV
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "DEXPLORER" in purple centered above Korean characters in purple.
Titulares e representantes
Titulares
Medicare Pharmaceuticals Inc.
Representantes
Leigh Ann Lindquist SUGHRUE MION, PLLC
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Recorded computer software for drug development using artificial intelligence; recorded computer software for analytics for clinical trial datafor data collectiondata analysisdata storingdata miningdata generationmachine learningall in drug discovery and drug development fields; recorded computer software for simulating drug development; recorded computer software for the analysis of data in the medical and biotechnology fields using algorithm for deep learning; recorded computer software based on artificial intelligence for image analysis and data analysis in the medical and biotechnology fields; recorded computer software for analysing medical diagnostic information; computer operating programsrecorded; recorded computer software for data processing; recorded medical software for pregnancy education; recorded medical software for uploadingstoring and submitting medical images for computer-aided diagnosis of respiratory medical conditions affecting humansproviding patient diagnosis risk assessmentsworkflow management and billing in the field of healthcare; recorded medical software for recordingprocessingtransmittingreceiving data for medical diagnostic and monitoring purposes; recorded medical software for aiding in the detection and diagnostics of congestive heart failure; recorded software for artificial intelligence conversionanalysisprocessingstorage and transmission
Classe 42
Drug discovery services; research for medical products; scientific research and technical consulting on the testinspection and research of medical products; development of pharmaceutical preparations and medicines; drug discovery services based on artificial intelligence; software design and development; computer software consultancy; application service provider featuring software for localwide and global communications networks which allow users to connect remote computers and computer networks together to exchange healthcare information and data; software as a service featuring software based on artificial intelligence for the analysis of deep learning image and data in the medical and biotechnology fields; platform as a service featuring computer software platform for data collectiondata analysisdata storage and data mining used in the healthcare and biotechnology fields; software as a service featuring software for data collectiondata analysisdata storage and data mining used in the healthcare and biotechnology fields; design of computer software for healthcare and medical institutions; installation and maintenance of computer software for healthcare and medical institutions; technical consultation related to medical researchbiotechnology data analysis and software development; technical consultation related to medical data analysis for research purposes; technical consultation related to software development in the medical field; research and development of computer software platform in the artificial intelligence field; software development for artificial intelligence service; drug discovery services through computer modeling methods; development of computer software for big data processing
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/08/2022
FIMP
FINAL DISPOSITION PROCESSED
11/08/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
22/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/01/2022
PUBO
PUBLISHED FOR OPPOSITION
04/01/2022
GPNX
NOTIFICATION PROCESSED BY IB
01/01/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/12/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
15/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/12/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/12/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/12/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/12/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/12/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/11/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/11/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15/11/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/11/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
15/11/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/11/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/11/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
15/11/2021
RFNT
REFUSAL PROCESSED BY IB
13/06/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/05/2021
RFRR
REFUSAL PROCESSED BY MPU
27/05/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/05/2021
CNRT
NON-FINAL ACTION WRITTEN
24/05/2021
DOCK
ASSIGNED TO EXAMINER
12/05/2021
MAFR
APPLICATION FILING RECEIPT MAILED
12/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/02/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/02/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DEXPLORER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.